| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 2.105 | 324 | 468 | 749 | 754 | 994 | 1.989 | 1.034 |
| Total Income - EUR | - | - | 2.105 | 324 | 468 | 749 | 754 | 994 | 1.989 | 1.034 |
| Total Expenses - EUR | - | - | 2.417 | 1.824 | 932 | 1.355 | 1.771 | 2.355 | 912 | 1.497 |
| Gross Profit/Loss - EUR | - | - | -312 | -1.500 | -465 | -606 | -1.017 | -1.361 | 1.077 | -463 |
| Net Profit/Loss - EUR | - | - | -375 | -1.510 | -479 | -626 | -1.017 | -1.361 | 904 | -463 |
| Employees | - | - | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Immunomed Center Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 9 | 0 | 0 | 0 | 0 | 0 | 546 | 407 |
| Current Assets | - | - | 1.848 | 548 | 331 | 255 | 363 | 260 | 930 | 347 |
| Inventories | - | - | 0 | 268 | 263 | 0 | 0 | 0 | 20 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | 1.848 | 280 | 69 | 255 | 363 | 260 | 910 | 347 |
| Shareholders Funds | - | - | -332 | -1.835 | -2.278 | -2.861 | -3.814 | -5.188 | -4.267 | -4.706 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 2.189 | 2.383 | 2.610 | 3.116 | 4.177 | 5.448 | 5.743 | 5.461 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Immunomed Center Srl